Gerresheimer certified for mould making in China

Injection moulding tools have been maintained and optimised at the Gerresheimer location in Dongguan, China. Since certification according to DIN ISO 9001, the company now also builds complete moulds. In this way, Gerresheimer makes itself more independent of local mould makers.

The maintenance and optimisation of molds are still part of the service offering. In addition to this, moulds for series production in Asia, Europe, and the US are manufactured there.

Manfred Baumann, Global Executive Vice President Sales and Marketing, Administration and TCC, Gerresheimer Medical Systems, said: “With the expanded portfolio of offerings in mould making, we adjust to the needs of our various customer segments. In the pharmaceuticals and medical technology markets, cost-efficient moulds that can be delivered quickly for start-ups and development projects are required. We now offer the appropriate solution for precisely this.”

Mould making in Dongguan consciously understands itself not as competition, but as supplementing the more comprehensive services in Wackersdorf, Germany, where highly complex, high-cavity moulds can be built for pharmaceutical and medical technology large series production. The China-based service is limited to moulds with an average degree of complexity.

In 2019, Gerresheimer began creating the process description, which is the prerequisite for certification according to the quality management standard DIN ISO 9001. The certification audit took place in May 2020 – digitally due to the pandemic.

The quality management system of the location is now certified by the DQS, and took effect on 19 July 2020.